Literature DB >> 16220509

A robust approach to t linear mixed models applied to multiple sclerosis data.

Tsung I Lin1, Jack C Lee.   

Abstract

We discuss a robust extension of linear mixed models based on the multivariate t distribution. Since longitudinal data are successively collected over time and typically tend to be auto-correlated, we employ a parsimonious first-order autoregressive dependence structure for the within-subject errors. A score test statistic for testing the existence of autocorrelation among the within-subject errors is derived. Moreover, we develop an explicit scoring procedure for the maximum likelihood estimation with standard errors as a by-product. The technique for predicting future responses of a subject given past measurements is also investigated. Results are illustrated with real data from a multiple sclerosis clinical trial.

Entities:  

Mesh:

Year:  2006        PMID: 16220509     DOI: 10.1002/sim.2384

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  4 in total

1.  SNP_NLMM: A SAS Macro to Implement a Flexible Random Effects Density for Generalized Linear and Nonlinear Mixed Models.

Authors:  David M Vock; Marie Davidian; Anastasios A Tsiatis
Journal:  J Stat Softw       Date:  2014-01-01       Impact factor: 6.440

2.  Influence assessment in censored mixed-effects models using the multivariate Student's-t distribution.

Authors:  Larissa A Matos; Dipankar Bandyopadhyay; Luis M Castro; Victor H Lachos
Journal:  J Multivar Anal       Date:  2015-10-01       Impact factor: 1.473

3.  Robust Bayesian inference for multivariate longitudinal data by using normal/independent distributions.

Authors:  Sheng Luo; Junsheng Ma; Karl D Kieburtz
Journal:  Stat Med       Date:  2013-03-11       Impact factor: 2.373

Review 4.  Harnessing repeated measurements of predictor variables for clinical risk prediction: a review of existing methods.

Authors:  Lucy M Bull; Mark Lunt; Glen P Martin; Kimme Hyrich; Jamie C Sergeant
Journal:  Diagn Progn Res       Date:  2020-07-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.